Investor Presentaiton slide image

Investor Presentaiton

NCT04177498: "A Pilot, Open Study to Assess Efficacy and Safety of Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated Locally Advanced/Metastatic Squamous Cell Carcinoma" USA site: Thomas Jefferson University, Philadelphia, PA Status: Active and Enrolling, oral arm is recruiting 0 ONCONOVA THERAPEUTICS
View entire presentation